Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05839210

Lifestyle Intervention of Food and Exercise for Lymphoma Survivors

Lifestyle Intervention of Food and Exercise for Lymphoma Survivors (LIFE - L)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
140 (estimated)
Sponsor
University of Miami · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate if a mediterranean diet and exercise program for Lymphoma patients during chemotherapy can improve treatment completion and reduce treatment-related side effects.

Conditions

Interventions

TypeNameDescription
BEHAVIORALLIFE-L Mediterranean DietMediterranean Diet will include goals of: 4+ vegetable servings (2-4 cups) daily, 2+ fruit servings (1.5-2 cups) daily, 2+ whole grain servings daily, 1+ legume serving daily, 1+ serving nuts and seeds daily, and seafood 2 times per week. Limit or avoid highly processed foods, sugar-sweetened beverages and foods, processed meats, red meat, and alcohol.
BEHAVIORALLIFE-L Home-Based Exercise ProgramThe Home-Based Exercise Program will include goals of: 150+ minutes moderate or 75+ minutes vigorous exercise per week, completed in sessions of at least 10-minute duration, including daily aerobic exercise plus two resistance-based exercise sessions per week.
BEHAVIORALSupportive MaterialsParticipants will receive an informational study notebook, an exercise reference poster and videos, a Fitbit, and three stretch bands of different intensities. Participants will also receive supportive and informational text messages or emails three (3) times per week during the study; participants can opt-out of these messages. Participants will be requested to utilize the Fitbit app to track exercise sessions, as well as the MyFitnessPal app to track their diet. Support to set up apps will be provided by research staff. For participants who choose not to use the app, a laminated diet and exercise tracking sheet with dry erase marker will be provided, and participants will be advised to send a picture of their completed tracking sheet by text message to research staff each week.

Timeline

Start date
2023-04-26
Primary completion
2026-10-31
Completion
2026-10-31
First posted
2023-05-03
Last updated
2026-01-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05839210. Inclusion in this directory is not an endorsement.